Skip to main content

BioCommunique Article

We invite you to imagine a world without limits at Biocom’s Annual ‘Celebration of Life’ Dinner with keynote speaker Gay Grossman.

Biocom’s Annual ‘Celebration of Life’ Dinner: Only One Table Remaining!

  • 2019-11-14T01:57:00.000+0000
  • California
  • Author: Ashleigh Farver

Bring your imagination to Biocom’s Annual Celebration of Life Dinner on November 21st, 2019 at the Hyatt Regency La Jolla At Aventine where we’ll recognize life science achievements from the past year and set the stage for a limitless 2020.

Imagine this…

An invisible world of microorganisms brought to light by researchers, charted by technology, and turned into discoveries by pioneers like you…

Discoveries that recognize diseases, pinpoint treatments, optimize medicines and identify cures. Discoveries that secure a better future for our children and challenge them to take us further…

To democratize the future of medicine, to empower every individual and to turn that same world of microorganisms into renewable biofuels that can propel us forward into the future of We.

Imagine this: a world without limits.

Keynote Speaker: Gay Grossman, Patient Advocate,

User-added image

Gay has been active in the Rare Disease community for over two decades and continues her efforts to build and support patient and family advocacy. Ten years ago, when she first spoke, she was the mother of a 12 year old daughter without a diagnosis. She shared her daughter’s experience of being physically disabled in a typical world. Soon the subject changed to how she and her husband made accommodations in schools and how they learned about the science which might someday be available and lead them to a diagnosis.

Finally in 2013, Gay was able to speak about the experience of getting a genetic diagnosis through whole genome sequencing, after not having a diagnosis for 15 years.

Today, her daughter is an adult and does her own advocacy. Gay has recently looked in the mirror and changed her speaking subject to her own Rare Disease experience of being a mother, the primary caregiver, and what it was like to live and love her daughter not knowing what was wrong. Together, Gay and her husband have built a dedicated team who help them keep the science moving towards a treatment. Together they founded, the foundation for ADCY5-related dyskinesia. They are advocates of shared data and patients owning their data. They maintain their focus to help all Rare Disease patients. Due to their work, this foundation now supports world-renowned researchers who study the gene, while they continue to build a community of hundreds, when they started with only 1.

Gay is currently the Director of Patient Engagement at Neurogene Inc.

FDA Spotlight: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs U.S. Food and Drug Administration

User-added image

Anna Abram is Deputy Commissioner for Policy, Legislation, and International Affairs for the U.S. Food and Drug Administration. She plays a critical role in overseeing the development and implementation of key policy initiatives and provides strategic policy direction to advance FDA’s mission and vision of protecting and promoting public health.

Learn more and register here.

*We only have ONE table left for purchase and limited seats remaining for general admission tickets. Don’t delay in getting your ticket or table today!

Thank you to our lead sponsors:

BioMed Realty

Fisher Scientific

To all of our sponsors, your dedicated support is deeply appreciated:
Thermo Fisher Scientific, Marsh & McLennan Agency, Ernst & Young, Genomics for Good, Halloran Consulting Group, BIO International Convention, NIIMBL, UPS, Business Wire, KPBS, Science History Institute and JT Macmillan Photography.

Biocom thanks our 2019 Annual Dinner table sponsors for supporting our life saving industry:
Ajinomoto Bio-Pharma Services
Bench International
BioMed Realty Trust, Inc.
Business Wire
California State University San Marcos
Canale Communications
Cooley LLP
Cushman & Wakefield
DLA Piper
Eli Lilly
Ernst & Young
Genomics for Good
Hale BioPharma Ventures
Halloran Consulting Group
Jones Day
Latham & Watkins
ManagedLab Services
Marsh & McLennan Agency
Millennium Health
Molecular Assemblies
Morrison & Foerster LLP
National Institute for Innovation in Manufacturing Biologics
Perkins Coie
Procopio LLP
Quotient Sciences, Ltd.
Rakuten Medical
Respivant Sciences
San Diego Regional EDC
SDSU: Div. of Research/College of Sci.
TEGA Therapeutics
ThermoFisher Scientific
Triphase Accelerator U.S. Corporation
UC San Diego Office of Research Affairs
Wilson Sonsini Goodrich & Rosati